The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats

Neuropharmacology

Volumn 79, Issue , 2014, Pages 634-641

  Andrzejewski, Matthew E ^a   Spencer, Robert C ^b   Harris, Rachel L ^b   Feit, Elizabeth C ^b   McKee, Brenda L ^c   Berridge, Craig W ^b  

^a UNIVERSITY OF WISCONSIN WHITEWATER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c EDGEWOOD COLLEGE   (United States)

Author keywords

Amphetamine; Attention; Behavioral inhibition; DRL; Methylphenidate; Rats; Signal detection

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; DIFFERENTIAL REINFORCEMENT OF LOW RATE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; INHIBITION (PSYCHOLOGY); LOCOMOTION; LOW DRUG DOSE; MALE; MENTAL TASK; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PRIORITY JOURNAL; RESPONSE TIME; SIGNAL DETECTION; SUSTAINED ATTENTION; WORKING MEMORY; ANIMAL; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; PERCEPTIVE DISCRIMINATION; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT;

AMPHETAMINE; ANIMALS; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SIGNAL DETECTION, PSYCHOLOGICAL;

EID: 84896711387     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.01.018     Document Type: Article

References (50)

1. M.E. Andrzejewski, C.D. Ryals, S. Higgins, J. Sulkowski, J. Doney, A.E. Kelley, and P.J. Bersh Is extinction the hallmark of operant discrimination? Reinforcement and S(Delta) effects (Research Support, N.I.H., Extramural) Behav. Process. 74 1 2007 49 63 10.1016/j.beproc.2006.09.010 (Pubitemid 44854328)
2. A.F. Arnsten The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex J. Pediatr. 154 5 2009 I S43
3. A.F. Arnsten, and A.G. Dudley Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder Behav. Brain Funct. 1 1 2005 2
4. A.F.T. Arnsten Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 185 208
5. C. Avila, I. Cuenca, V. Felix, M.A. Parcet, and A. Miranda Measuring impulsivity in school-aged boys and examining its relationship with ADHD and ODD ratings J. Abnorm. Child Psychol. 32 3 2004 295 304 (Pubitemid 39004757)
6. M. Balcells-Olivero, M.S. Cousins, and L.S. Seiden Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia J. Pharmacol. Exp. Ther. 286 2 1998 742 752 (Pubitemid 29003464)
7. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F. Arnsten, A.E. Kelley, B. Schmeichel, and R.C. Spencer Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function (Comparative Study Research Support, N.I.H., Extramural) Biol. Psychiatry 60 10 2006 1111 1120 10.1016/j.biopsych.2006.04.022 (Pubitemid 44647216)
8. C.W. Berridge, J.S. Shumsky, M.E. Andrzejewski, J.A. McGaughy, R.C. Spencer, D.M. Devilbiss, and B.D. Waterhouse Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha - and alpha-receptors (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.) Biol. Psychiatry 71 5 2012 467 473 10.1016/j.biopsych.2011.07.022
9. C.W. Berridge, and T.A. Stalnaker Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex Synapse 46 3 2002 140 149 (Pubitemid 35155167)
10. L. Bizarro, S. Patel, C. Murtagh, and I.P. Stolerman Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate Behav. Pharmacol. 15 3 2004 195 206 (Pubitemid 38859602)
11. P.J. Bushnell Behavioral approaches to the assessment of attention in animals Psychopharmacology (Berl) 138 3-4 1998 231 259 (Pubitemid 28365488)
12. R.N. Cardinal, D.R. Pennicott, C.L. Sugathapala, T.W. Robbins, and B.J. Everitt Impulsive choice induced in rats by lesions of the nucleus accumbens core Science 292 5526 2001 2499 2501 (Pubitemid 32601663)
13. T.K. Daugherty, and H.C. Quay Response perseveration and delayed responding in childhood behavior disorders J. Child Psychol. Psychiatry 32 3 1991 453 461
14. G.A. Gescheider Psychophysics: Method, Theory and Application second ed. 1985 Lawrence Erlbaum Associates Hillsdale, NJ
15. D.M. Green, and J. Swets Signal Detection Theory and Psychophysics 1966 Wiley and Sons, Inc New York
16. L.L. Greenhill Clinical effects of stimulant medication in ADHD M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 31 71
17. J.B. Grier Nonparametric indexes for sensitivity and bias: computing formulas Psychol. Bull. 75 6 1971 424 429
18. D.M. Grilly A verification of psychostimulant-induced improvement in sustained attention in rats: effects of d-amphetamine, nicotine, and pemoline Exp. Clin. Psychopharmacol. 8 1 2000 14 21 (Pubitemid 30417786)
19. D.M. Grilly, and A. Loveland What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats? Psychopharmacology (Berl) 153 2 2001 155 169 (Pubitemid 32127883)
20. D.J. Heal, S.L. Smith, R.S. Kulkarni, and H.L. Rowley New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD (Research Support, Non-U.S. Gov't Review) Pharmacol. Biochem. Behav. 90 2 2008 184 197 10.1016/j.pbb.2008. 03.016
21. A. Jackson, W. Koek, and F.C. Colpaert Can the DRL 72s schedule selectively reveal antidepressant drug activity? Psychopharmacology (Berl) 117 2 1995 154 161
22. R. Kuczenski, and D.S. Segal Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine J. Pharmacol. Exp. Ther. 296 3 2001 876 883 (Pubitemid 32187360)
23. R. Kuczenski, and D.S. Segal Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine J. Neurosci. 22 16 2002 7264 7271
24. N.A. Macmillan, and C.D. Creelman Detection Theory: a User's Guide second ed. 2005 NJ Erlbaum Mahwah
25. F.D. McClure, and M. Gordon Performance of disturbed hyperactive and nonhyperactive children on an objective measure of hyperactivity J. Abnorm. Child Psychol. 12 4 1984 561 571 (Pubitemid 15203273)
26. J. McGaughy, and M. Sarter Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology (Berl) 117 3 1995 340 357
27. M.A. Mehta, A.M. Owen, B.J. Sahakian, N. Mavaddat, J.D. Pickard, and T.W. Robbins Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain J. Neurosci. 20 6 2000 RC65
28. K.S. Milar Cholinergic drug effects on visual discriminations: a signal detection analysis Psychopharmacology (Berl) 74 4 1981 383 388 (Pubitemid 11003763)
29. J. Monterosso, and G. Ainslie Beyond discounting: possible experimental models of impulse control Psychopharmacology (Berl) 146 4 1999 339 347 (Pubitemid 29513275)
30. D.B. Neill Frontal-striatal control of behavioral inhibition in the rat Brain Res. 105 1 1976 89 103
31. D.B. Neill, and J.G. Herndon Anatomical specificity within rat striatum for the dopaminergic modulation of DRL responding and activity Brain Res. 153 1978 529 538 (Pubitemid 8404681)
32. J.M. O'Donnell, G.J. Marek, and L.S. Seiden Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low- rate (DRL) operant schedule Neurosci. Biobehav. Rev. 29 4-5 2005 785 798 (Pubitemid 40755464)
33. W.M. Oshiro, Q.T. Krantz, and P.J. Bushnell A search for residual behavioral effects of trichloroethylene (TCE) in rats exposed as young adults Neurotoxicol. Teratol. 26 2 2004 239 251 (Pubitemid 38331994)
34. G. Paolone, C.C. Angelakos, P.J. Meyer, T.E. Robinson, and M. Sarter Cholinergic control over attention in rats prone to attribute incentive salience to reward J. Neurosci. 33 19 2013 8321 8335
35. J.D. Peterson, M.E. Wolf, and F.J. White Impaired DRL 30 performance during amphetamine withdrawal Behav. Brain Res. 143 1 2003 101 108 (Pubitemid 36802189)
36. M.A. Pezze, J.W. Dalley, and T.W. Robbins Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task Neuropsychopharmacology 32 2 2007 273 283 (Pubitemid 46106934)
37. M.A. Pezze, J.W. Dalley, and T.W. Robbins Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride Psychopharmacology (Berl) 202 1-3 2009 307 313
38. T. Puumala, and J. Sirvio Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task Neuroscience 83 2 1998 489 499 (Pubitemid 28062639)
39. J.L. Rapoport, M.S. Buchsbaum, H. Weingartner, T.P. Zahn, C. Ludlow, and E.J. Mikkelsen Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men Arch. Gen. Psychiatry 37 8 1980 933 943 (Pubitemid 10034569)
40. J.L. Rapoport, M.S. Buchsbaum, T.P. Zahn, H. Weingartner, C. Ludlow, and E.J. Mikkelsen Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys Science 199 4328 1978 560 563 (Pubitemid 8298043)
41. T.W. Robbins, and A.F. Arnsten The neuropsychopharmacology of fronto-executive function: monoaminergic modulation Annu. Rev. Neurosci. 32 2009 267 287
42. K.E. Sabol, J.B. Richards, K. Layton, and L.S. Seiden Amphetamine analogs have differential effects on DRL 36-s schedule performance Psychopharmacology (Berl) 121 1 1995 57 65
43. T. Sagvolden, E.B. Johansen, G. Woien, S.I. Walaas, J. Storm-Mathisen, L.H. Bergersen, and S.V. Faraone The spontaneously hypertensive rat model of ADHD-the importance of selecting the appropriate reference strain (Research Support, N.I.H., Extramural Review) Neuropharmacology 57 7-8 2009 619 626 10.1016/j.neuropharm.2009.08.004
44. D.S. Segal Behavioral characterization of d- and l-amphetamine: neurochemical implications Science 190 4213 1975 475 477
45. L.S. Seiden, J. Andresen, and R.C. MacPhail Methylphenidate and d-amphetamine: effects and interactions with alphamethyltyrosine and tetrabenazine on DRL performance in rats Pharmacol. Biochem. Behav. 10 4 1979 577 584 (Pubitemid 9182905)
46. M.V. Solanto Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration Behav. Brain Res. 94 1 1998 127 152 (Pubitemid 28352470)
47. J. Swets, W.P. Tanner Jr., and T.G. Birdsall Decision processes in perception Psychol. Rev. 68 1961 301 340
48. C.J. Vaidya, G. Austin, G. Kirkorian, H.W. Ridlehuber, J.E. Desmond, G.H. Glover, and J.D. Gabrieli Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study Proc. Natl. Acad. Sci. U. S. A. 95 24 1998 14494 14499 (Pubitemid 28549395)
49. T.E. Wilens, S.V. Faraone, and J. Biederman Attention-deficit/ hyperactivity disorder in adults Jama 292 5 2004 619 623 (Pubitemid 39014414)
50. A.J. Wilkins, T. Shallice, and R. McCarthy Frontal lesions and sustained attention Neuropsychologia 25 2 1987 359 365 (Pubitemid 17080380)